非経口栄養剤の市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析：栄養剤タイプ別（単回投与アミノ酸溶液、非経口脂質エマルジョン、炭水化物、微量元素、ビタミン・ミネラル）、エンドユーザー別（病院、診療所、その他）

Parenteral Nutrition Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)

非経口栄養剤の市場規模は2022年に68.4億米ドルと評価され、2030年には112.1億米ドルに達すると予測されている。2022年から2030年までの年平均成長率は6.2%と推定される。非経口栄養剤は、水分、ビタミン、ミネ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2024年2月1日	US$5,190 シングルユーザライセンスライセンス・価格情報注文方法はこちら	154	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

非経口栄養剤の市場規模は2022年に68.4億米ドルと評価され、2030年には112.1億米ドルに達すると予測されている。2022年から2030年までの年平均成長率は6.2%と推定される。
非経口栄養剤は、水分、ビタミン、ミネラル、微量元素、アミノ酸、電解質を含む静脈内投与の栄養補給の一種である。経腸（胃または腸）栄養と比較して、非経口栄養はより複雑で費用がかかり、感染症のリスクが高く、入院期間が長くなる。非経口栄養が処方されるのは、経腸的に栄養を摂取できない患者のみである。非経口栄養療法の目標には、栄養状態の回復、低タンパク血症の治療、筋力低下の回復、およびその他の栄養欠損の補充が含まれる。

非経口栄養療法の市場動向には、栄養製品の処方における技術革新が含まれる。消費者の積極的な健康管理を支援する製品、特にエネルギーレベル、免疫力、疾病治療といった特定のニーズに焦点を当てた製品に対する需要が急増している。病気の種類によって必要な栄養は異なる。非経口製品の機能性と特異的な処方は、患者に提供される既存の治療を妨げず、必要条件に従ってより正確で強化された治療を提供するのに役立つ。非経口栄養の大栄養素および微量栄養素の製剤とその用途は、がんや消化器疾患などの病気の種類によって異なる。
革新的な製剤の著しい発展により、患者一人ひとりの病状だけでなく、あらゆる個人の要求を満たすように設計された栄養ソリューションの新時代が到来した。このレベルの個別化は、非経口栄養の効果を高めるだけでなく、患者の転帰を改善する。製剤の革新により、市場は新生児から高齢者、特定の病状を持つ患者まで、さまざまな患者の独自の栄養ニーズを完全に満たすことができる。例えば、安定性と生物学的利用能が改善された脂質ベースの乳剤の出現は、特に未熟児の治療において、静脈栄養の様相を変えつつある。さらに、従来の栄養剤につきものの問題や副作用のリスクも、こうした製剤革新のおかげで軽減されている。医療エコシステム内での非経口栄養の採用促進と患者ケアの改善という2つの利点があるため、この業界は例外的な成長と長期的な成功を収めることができる。
.
栄養タイプ別、非経口栄養市場ベースの洞察
非経口栄養市場は、栄養タイプ別に、単回投与アミノ酸溶液、非経口脂質エマルジョン、炭水化物、微量元素、ビタミン・ミネラルに区分される。2022年には、単回投与アミノ酸溶液セグメントが非経口栄養剤市場シェアを独占し、非経口脂質エマルジョンセグメントが予測期間中に最も高いCAGRを記録する可能性が高い。重症患者のタンパク異化を遅らせるために、大量のタンパク質を供給するが、有害なエネルギー量は供給しない非経口アミノ酸のような栄養療法に対するニーズが高まっている。
非経口栄養市場：エンドユーザー別洞察
エンドユーザー別では、非経口栄養剤市場は病院、診療所、その他に分類される。病院セグメントは2022年に市場で最大のシェアを占めたが、クリニックセグメントは2022～2030年の非経口栄養剤市場で最も高いCAGRを記録すると予測されている。病院は、利用可能なすべての施設を持っている最大の事業体と考えられている。病院はまた、保険請求で払い戻しが可能なさまざまな診断および治療施設を提供している。病院は、様々な医師、専門医、および強化された医療サービスを提供する他の専門家と関連している。あらゆる種類の循環器疾患は病院で治療することができる。病院は、さまざまな病気に苦しむ患者に、看護サービスを含む広範な医療サービスを提供することで、重要な役割を果たしている。このため、病院内の患者の間で、いくつかの疾患や手術に対する経皮薬物送達システムの採用が増加した。
Medicines and Healthcare Regulatory Authority、Element-Nutrition-Deck、Office for National Statistics、National Institute for Clinical Excellenceなどは、非経口栄養市場に関する報告書を作成する際に参照した主な二次情報源の一部である。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Parenteral Nutrition Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Parenteral Nutrition Market Landscape
4.1 Overview
4.2 Global PEST Analysis
5. Parenteral Nutrition Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surge in Cases of Malnutrition and Premature Births
5.2 Market Restraints
5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
5.3 Market Opportunities
5.3.1 New Product Developments by Companies
5.4 Future Trends
5.4.1 Innovation in Formulations of Nutrition Products
5.5 Impact Analysis
6. Parenteral Nutrition Market - Global Market Analysis
6.1 Parenteral Nutrition Market Revenue (US$ Mn), 2022 – 2030
7. Parenteral Nutrition Market Analysis – by Nutrient Type
7.1 Overview
7.2 Single Dose Amino Acid Solution
7.2.1 Overview
7.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Parenteral Lipid Emulsion
7.3.1 Overview
7.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Carbohydrates
7.4.1 Overview
7.4.2 Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Trace Elements
7.5.1 Overview
7.5.2 Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Vitamins and Minerals
7.6.1 Overview
7.6.2 Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8. Parenteral Nutrition Market Analysis – by End User
8.1 Overview
8.2 Hospitals
8.2.1 Overview
8.2.2 Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Clinics
8.3.1 Overview
8.3.2 Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9. Parenteral Nutrition Market – Geographical Analysis
9.1 North America: Parenteral Nutrition Market
9.1.1 Overview
9.1.2 North America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.1 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type
9.1.2.2 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User
9.1.3 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
9.1.3.1 United States: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.3.1.1 Overview
9.1.3.1.2 United States: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.3.1.3 United States: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.1.3.1.4 United States: Parenteral Nutrition Market Breakdown, by End User
9.1.3.2 Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.3.2.1 Overview
9.1.3.2.2 Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.3.2.3 Canada: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.1.3.2.4 Canada: Parenteral Nutrition Market Breakdown, by End User
9.1.3.3 Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.3.3.1 Overview
9.1.3.3.2 Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.1.3.3.3 Mexico: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.1.3.3.4 Mexico: Parenteral Nutrition Market Breakdown, by End User
9.2 Europe
9.2.1 Overview
9.2.2 Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.2.1 Europe: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type
9.2.2.2 Europe: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User
9.2.3 Europe: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.1.1 Overview
9.2.3.1.2 Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.1.3 Germany: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.2.3.1.4 Germany: Parenteral Nutrition Market Breakdown, by End User
9.2.3.2 United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.2.1 Overview
9.2.3.2.2 United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.2.3 United Kingdom: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.2.3.2.4 United Kingdom: Parenteral Nutrition Market Breakdown, by End User
9.2.3.3 France: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.3.1 Overview
9.2.3.3.2 France: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.3.3 France: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.2.3.3.4 France: Parenteral Nutrition Market Breakdown, by End User
9.2.3.4 Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.4.1 Overview
9.2.3.4.2 Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.4.3 Italy: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.2.3.4.4 Italy: Parenteral Nutrition Market Breakdown, by End User
9.2.3.5 Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.5.1 Overview
9.2.3.5.2 Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.5.3 Spain: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.2.3.5.4 Spain: Parenteral Nutrition Market Breakdown, by End User
9.2.3.6 Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.6.1 Overview
9.2.3.6.2 Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.2.3.6.3 Rest of Europe: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.2.3.6.4 Rest of Europe: Parenteral Nutrition Market Breakdown, by End User
9.3 Asia Pacific
9.3.1 Overview
9.3.2 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type
9.3.2.2 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User
9.3.3 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.1.1 Overview
9.3.3.1.2 China: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.3.3.1.4 China: Parenteral Nutrition Market Breakdown, by End User
9.3.3.2 Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.2.1 Overview
9.3.3.2.2 Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.3.3.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
9.3.3.3 India: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.3.1 Overview
9.3.3.3.2 India: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.3.3.3.4 India: Parenteral Nutrition Market Breakdown, by End User
9.3.3.4 Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.4.1 Overview
9.3.3.4.2 Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.3.3.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
9.3.3.5 South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.5.1 Overview
9.3.3.5.2 South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.3.3.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
9.3.3.6 Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.6.1 Overview
9.3.3.6.2 Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3.6.3 Rest of APAC: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.3.3.6.4 Rest of APAC: Parenteral Nutrition Market Breakdown, by End User
9.4 Middle East and Africa
9.4.1 Overview
9.4.2 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type
9.4.2.2 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User
9.4.3 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.1.1 Overview
9.4.3.1.2 Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.1.3 Saudi Arabia: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.4.3.1.4 Saudi Arabia: Parenteral Nutrition Market Breakdown, by End User
9.4.3.2 United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.2.1 Overview
9.4.3.2.2 United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.2.3 United Arab Emirates: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.4.3.2.4 United Arab Emirates: Parenteral Nutrition Market Breakdown, by End User
9.4.3.3 South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.3.1 Overview
9.4.3.3.2 South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.3.3 South Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.4.3.3.4 South Africa: Parenteral Nutrition Market Breakdown, by End User
9.4.3.4 Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.4.1 Overview
9.4.3.4.2 Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4.3.4.3 Rest of Middle East and Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.4.3.4.4 Rest of Middle East and Africa: Parenteral Nutrition Market Breakdown, by End User
9.5 South and Central America
9.5.1 Overview
9.5.2 The South & Central South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.2.1 South and Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type
9.5.2.2 South and Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User
9.5.3 South and Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3.1.1 Overview
9.5.3.1.2 Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3.1.3 Brazil: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.5.3.1.4 Brazil: Parenteral Nutrition Market Breakdown, by End User
9.5.3.2 Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3.2.1 Overview
9.5.3.2.2 Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3.2.3 Argentina: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.5.3.2.4 Argentina: Parenteral Nutrition Market Breakdown, by End User
9.5.3.3 Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3.3.1 Overview
9.5.3.3.2 Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3.3.3 Rest of South and Central America: Parenteral Nutrition Market Breakdown, by Nutrient Type
9.5.3.3.4 Rest of South and Central America: Parenteral Nutrition Market Breakdown, by End User
10. Industry Landscape
10.1 Overview
10.1.1 Overview
11. Company Profiles
11.1 ICU Medical Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Grifols SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Pfizer Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Otsuka Pharmaceuticals Co Ltd
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Baxter International Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 B Braun SE
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Fresenius Kabi AG
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Vifor Pharma Management AG
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Aculife Healthcare Pvt Ltd
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The parenteral nutrition market size was valued at US$ 6.84 billion in 2022 and is expected to reach US$ 11.21 billion by 2030. The market is estimated to register a CAGR of 6.2% from 2022 to 2030.
Parenteral nutrition is a type of nutritional supplementation administered intravenously that includes fluids, vitamins, minerals, trace elements, amino acids, and electrolytes. Compared to enteral (gastric or intestinal) feeding, parenteral nutrition is more complex, more costly, and linked to a higher risk of infection and longer hospital stays. Only patients who are unable to receive nutrition enterally are prescribed parenteral nutrition. The goals of parenteral nutrition therapy include restoring nutritional status, treating hypoproteinemia, fixing muscle weakness, and replacing other nutritional deficits.

The parenteral nutrition market trends include innovation in formulations of nutrition products. There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.
Significant developments in innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care.
.
By Nutrient Type, Parenteral Nutrition Market-Based Insights
The parenteral nutrition market, by nutrient type, is segmented into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals. In 2022, the single dose amino acid solution segment dominated the parenteral nutrition market share; and the parenteral lipid emulsion segment is likely to register the highest CAGR during the forecast period. There is a growing need for nutrition therapies such as parenteral amino acids that deliver a substantial amount of protein, but not a toxic amount of energy, to slow down protein catabolism in critically ill patients.
By End User, Parenteral Nutrition Market -Based Insights
In terms of end user, the parenteral nutrition market is categorized into hospitals, clinics, and others. The hospitals segment held the largest share of the market in 2022; however, the clinic segment is anticipated to register the highest CAGR in the parenteral nutrition market during 2022-2030. Hospitals are considered the largest entities that have all the facilities available. Hospitals also provide various diagnostics and treatment facilities that can be reimbursed under insurance claims. Hospitals are associated with various doctors, specialists’ doctors, and other professionals who provide enhanced healthcare services. All types of cardiovascular diseases can be treated in hospitals. Hospitals serve a substantial role by providing extensive medical services, including nursing services, to patients suffering from a variety of diseases. This increased the adoption of transdermal drug delivery systems for several diseases and surgeries among patients in hospitals.
Medicines and Healthcare Regulatory Authority, Element-Nutrition-Deck, Office for National Statistics, and National Institute for Clinical Excellence are a few of the major secondary sources referred to while preparing the report on the parenteral nutrition market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?